Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study

被引:51
作者
Hoke, Robert S. [1 ]
Mueller-Werdan, Ursula [1 ]
Lautenschlaeger, Christine [2 ]
Werdan, Karl [1 ]
Ebelt, Henning [1 ]
机构
[1] Halle Saale Univ Hosp, Dept Med, D-06097 Halle, Saale, Germany
[2] Univ Halle Wittenberg, Inst Med Epidemiol Biometr & Informat, D-06097 Halle, Saale, Germany
关键词
Cardiogenic shock; Heart rate reduction; Multiple organ failure; Resting heart rate; Septic shock; Tachycardia; ACUTE MYOCARDIAL-INFARCTION; CURRENT INHIBITOR IVABRADINE; PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; INTENSIVE-CARE UNITS; RATE REDUCTION; SEPTIC SHOCK; I-F; AUTONOMIC DYSFUNCTION; SEVERE SEPSIS;
D O I
10.1007/s00392-011-0375-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To study the association between baseline heart rate and outcome in patients with multiple organ dysfunction (MODS) as well as the course of heart rate over the first 4 days during MODS. Prospective observational study in 89 patients with MODS, defined as an APACHE-II score a parts per thousand yen20. Baseline heart rate (HR0) was determined over a 60-minute period at the time of MODS diagnosis. 28-day all-cause mortality was the primary endpoint of the study, a fall of the APACHE-II score by 4 points or more from day 0 to day 4 constituted the secondary endpoint. Hazard ratios for heart rate of 90 beats per minute (bpm) or greater relative to less than 90 bpm were calculated using Cox proportional hazards model and adjusted for confounding variables. Median baseline heart rate was 83 bpm in survivors and 92 bpm in non-survivors (p = 0.048). 28-day mortality was 32 and 61% in patients with HR0 < 90 bpm and HR0 a parts per thousand yen 90 bpm, respectively. The adjusted hazard ratio for 28-day mortality was 2.30 (95% confidence interval 1.21-4.36, p = 0.001) for HR0 a parts per thousand yen 90 bpm relative to HR0 < 90 bpm. No correlation was found between baseline heart rate and the secondary endpoint. From day 0 to day 4, heart rate remained elevated in all patients, as well as in survivors and non-survivors. A heart rate a parts per thousand yen90 bpm at the time of MODS diagnosis is an independent risk factor for increased 28-day mortality. As in patients with cardiovascular conditions such as coronary heart disease or chronic heart failure, heart rate might constitute a target for heart rate-lowering therapy in the narrow initial treatment window of MODS.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 55 条
[1]   Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-adrenoceptor blockade in severe sepsis in rats [J].
Ackland, Gareth L. ;
Yao, Song T. ;
Rudiger, Alain ;
Dyson, Alex ;
Stidwill, Ray ;
Poputnikov, Dmitry ;
Singer, Mervyn ;
Gourine, Alexander V. .
CRITICAL CARE MEDICINE, 2010, 38 (02) :388-394
[2]   ULTIMATE SURVIVAL FROM SEPTIC SHOCK [J].
AZIMI, G ;
VINCENT, JL .
RESUSCITATION, 1986, 14 (04) :245-253
[3]  
BENEDICT CR, 1978, Q J MED, V47, P1
[4]  
Böhm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
[5]   ALTERATIONS IN CIRCULATING VASOACTIVE SUBSTANCES IN THE CRITICALLY ILL - A COMPARISON BETWEEN SURVIVORS AND NONSURVIVORS [J].
BOLDT, J ;
MENGES, T ;
KUHN, D ;
DIRIDIS, C ;
HEMPELMANN, G .
INTENSIVE CARE MEDICINE, 1995, 21 (03) :218-225
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   Sir Isaac Newton, sepsis, SIRS, and CARS [J].
Bone, RC .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1125-1128
[8]   Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs [J].
Colin, P ;
Ghaleh, B ;
Monnet, X ;
Hittinger, L ;
Berdeaux, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (01) :236-240
[9]   Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials [J].
Cucherat, Michel .
EUROPEAN HEART JOURNAL, 2007, 28 (24) :3012-3019
[10]   Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure [J].
De Ferrari, Gaetano M. ;
Mazzuero, Antonio ;
Agnesina, Laura ;
Bertoletti, Alessandra ;
Lettino, Maddalena ;
Campana, Carlo ;
Schwartz, Peter J. ;
Tavazzi, Luigi .
EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (06) :550-555